INTERNATIONAL PATENT: ZEALAND PHARMA A/S FILES APPLICATION FOR "PETRELINTIDE FOR USE IN THE TREATMENT OF OBESITY, DIABETES OR A DISEASE LINKED TO OBESITY OR DIABETES, OR OF REDUCING BODY WEIGHT, INHIBITING WEIGHT GAIN OR REDUCING FOOD INTAKE"

GENEVA, Dec. 29 -- ZEALAND PHARMA A/S (Sydmarken 112860 Soborg) filed a patent application (PCT/EP2025/067421) for "PETRELINTIDE FOR USE IN THE TREATMENT OF OBESITY, DIABETES OR A DISEASE LINKED TO OBESITY OR DIABETES, OR OF REDUCING BODY WEIGHT, INHIBITING WEIGHT GAIN OR REDUCING FOOD INTAKE" on Jun 20, 2025. With publication no. WO/2025/262301, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GRIFFIN, Jonathan (c/o Zealand Pharma A/SSydmarken 112860 Soborg), HESSE, Dan (c/o Zealand Pharma A/SSydmarken 112860 Soborg)

Abs...